Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors.
Description
Cancer chemotherapy and pharmacology; 05/01/2024(AN 38436714); ISSN: 1432-0843MEDLINE Ultimate
